Elena Verri - Concepedia

Author

Elena Verri

European Institute of Oncology ORCID

Also Known As

E Verri, E. Verri, Elena Verri, Verri, Elena

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

European Institute of Oncology Istituti di Ricovero e Cura a Carattere Scientifico University of Turin Casa Sollievo della Sofferenza University of Milan

About

Elena Verri is an author at European Institute of Oncology specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	587
2	Health Sciences	2	2	88
3	Biostatistics	1	1	70
4	Cell Biology	1	1	161
5	Orthopaedics	1	1	59

Elena Verri

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II–III trial Maria Grazia Ghi, Adriano Paccagnella, Daris Ferrari, Annals of Oncology	2017	197
Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications Franco Nolè, Elisabetta Munzone, Laura Zorzino, Annals of Oncology Metastatic Breast CancerBreast OncologyMedicinePathologyBreast Cancer	2007	161
HER2/neu Oncoprotein Overexpression in Epithelial Ovarian Cancer: Evaluation of its Prevalence and Prognostic Significance Elena Verri, Pamela Guglielmini, Matteo Puntoni, Oncology	2005	136
Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer Edoardo Botteri, Maria Teresa Sandri, Vincenzo Bagnardi, Breast Cancer Research and Treatment Metastatic Breast CancerBreast OncologyTumour Cells NumberTumor HeterogeneityMedicine	2009	70
Hormone‐receptor expression and activity of trastuzumab with chemotherapy in HER2‐positive advanced breast cancer patients Filippo Montemurro, Valentina Rossi, Maria Cossu Rocca, Cancer	2011	68
Concomitant chemoradiation (CRT) or cetuximab/RT (CET/RT) versus induction Docetaxel/ Cisplatin/5-Fluorouracil (TPF) followed by CRT or CET/RT in patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN). A randomized phase III factorial study (NCT01086826). Maria Grazia Ghi, Adriano Paccagnella, Daris Ferrari, Journal of Clinical Oncology Surgical OncologyInduction TpfPharmacotherapyOral CancerRadiation Medicine	2014	66
Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer Giuseppina Sanna, Lorenzo Preda, Roberto Bruschini, Annals of Oncology Jaw OsteonecrosisBone DiseaseBreast OncologyMedicineBreast Cancer	2006	59
First-Line PAzopanib in NOn–clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA Study Sebastiano Buti, Melissa Bersanelli, Francesca Maines, Clinical Genitourinary Cancer UrologyGenitourinary CancerKidney ResearchMedicineSurgical Pathology	2016	54
Participation in Clinical Trials as Viewed by the Patient: Understanding Cultural and Emotional Aspects Which Influence Choice Chiara Catania, Tommaso De Pas, Aron Goldhirsch, Oncology	2008	48
Brain metastases in patients with advanced breast cancer. Giuseppina Sanna, L. Franceschelli, Nicole Rotmensz, PubMed	2007	43

Page 1